2022 in review: Updates in EGFR-mutant NSCLC

Learning objective:

After watching this broadcast, participants should be able to:

• Review latest data on the diagnosis and management of patients with EGFR-mutant NSCLC from 2022
• Understand how key learnings from 2022 translate into clinical practice to improve patient outcomes

Scientific Committee:

• Matthew Krebs (UK)
• Antonio Passaro (Italy)
• Jarushka Naidoo (Ireland)
• Anne-Marie Dingemans (The Netherlands)

Claim your CPD credits
The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim 1.0 credits for this activity.

Name of activity: Janssen Oncology Medical Education Webinar (OME) 2022 in review: Updates in EGFR-mutant NSCLC
Certificate number: A032958
Date of activity: December 2022 CPD
Provider: Sciterion 013096